Cervical Cancer Screening and Vaccination: Knowledge, Awareness, and Attitude of Female Staff in a Nigerian University

doi:10.21203/rs.3.rs-2390159/v1

Download PDF

Research Article

Cervical Cancer Screening and Vaccination: Knowledge, Awareness, and Attitude of Female Staff in a Nigerian University

https://doi.org/10.21203/rs.3.rs-2390159/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 03 May, 2023

Read the published version in BMC Women's Health →

You are reading this latest preprint version

Background: Poor knowledge and awareness of cervical cancer screening and vaccination are significant barriers to effective cervical cancer prevention in developing countries. Knowledge of cervical cancer and vaccination against cervical cancer remains low in Nigeria. The purpose of this study was to assess knowledge, awareness, and attitude of female staff of Afe Babalola University towards cervical cancer screening and vaccinations.

Methods: This study was a cross-sectional study conducted using a semi-structured questionnaire among the female staff of Afe Babalola University, Ado Ekiti, Ekiti State, Nigeria. The workers’ knowledge and awareness were assessed using yes and no questions while the attitude was assessed using Likert scale questions. The workers’ knowledge was ranked as good (>50%) and poor (<50%). The relationship between demographics, attitude and knowledge of cervical cancer screening and vaccination was carried out using the Chi-square test. Analyses were conducted using SPSS software version 20.

Results: A total of 200 staff consented to participate in the study out of which 64% were married with mean age 32.81 + 8.164 years. Majority (60.5%) of the participants knew the causes of cervical cancer while 7.5% strongly agreed that they do not see the need for cervical screening. Majority (63.5%) of the participants showed good knowledge while 46% had a positive attitude towards cervical cancer screening and vaccination.

Conclusions: The study participants showed good knowledge and awareness but poor attitude towards cervical cancer screening and vaccinations. Interventions and continuous education are needed to improve the population’s attitude and eliminate misconceptions.

Cervical cancer screening

Awareness

Knowledge

Attitude

Female workers

Nigeria

Cervical cancer is the fourth most frequent cancer in women worldwide, with 604 000 new cases and 342 000 deaths in 2020 [1]. In 2020, low- and middle-income nations accounted for over 90% of cervical cancer new cases and related deaths worldwide [2]. Cervical cancer death rate has also been reported to be 18 times higher in low income countries than in developed countries [3] and some nations in Sub-Saharan Africa, Latin America, and Asia have exceptionally high cervical cancer-related death rates [4, 5].

Cervical cancer is the second most frequent cancer among Nigerian women aged 15 to 44 with over 14,000 new diagnoses and more than 20 deaths daily [4, 6]. Also, Nigeria has one of the highest rates of human papillomavirus (HPV)-related diseases in Sub-Saharan Africa [7] and research findings suggest that HPV is highly prevalent among Nigerian women. According to Aminu et al (2014) [8], Immunoglobulin G (IgG) antibodies against HPV had a prevalence above 40 percent among Nigerian women in the northern region. HPV infection rates in female outpatients in Southwest Nigeria have also been reported to range from 30.4 percent 36.5 percent [9, 10].

A persistent infection with the sexually transmitted human papillomavirus (HPV) is the most common cause of cervical cancer [11]. HPV is responsible for 90–100% of cervical cancer cases in women, especially those under the age of 35 [12]. HPV is the most prevalent viral infection of the female reproductive system and majority of sexually active women and men will become infected at some point in their lives while some will become infected multiple times [1]. HPV types can be classed as high-risk or low-risk [13]. The high risk HPV 16 and 18 subtypes are the most common subtypes of HPV, accounting for 70% of cervical cancer occurrences [11, 14]. Similarly, high-risk HPV was found in all of the women in a Nigerian sample of women with abnormal cytology, with HPV genotype 35, 31, 16, and 18 accounting for 40%, 30%, 20%, and 10% of the cases, respectively [15]. Research has also found a link between HPV 16 and 18 subtypes and malignant tumours of the penis, vulva, and anus [14, 16].

Despite documented evidence of HPV being highly associated with cervical cancer, other risk factors such as smoking, sexual activity at a young age, low socioeconomic level, poor personal and sexual hygiene, having several sexual partners, increased parity, as well as infection with HIV have all been identified as risk factors for cervical cancer [3, 17]. Cervical cancer and HIV are interrelated and women living with HIV are 4-10 times more likely to develop cervical cancer than HIV-negative women and more likely to develop it at a younger age accounting for about 5% of all cervical cancer occurrences [18, 19].

Comprehensive prevention and control strategies for cervical cancer have been proposed by the World Health Organisation in 2020 [20]. The strategies encompassed primary, secondary and tertiary prevention strategies such as community education, social mobilization, vaccination, screening, treatment and palliative care. Vaccination against HPV, pre-cancerous lesion screening and therapy, early identification and rapid treatment of invasive malignancies, and palliative care are established cost-effective options for addressing cervical cancer across the care continuum [21]. Expanded HPV vaccination coverage is expected to eradicate roughly 70% of cervical cancers globally, and cervical cancer screening performed by women in their 30s or 40s could reduce the risk of cervical cancer by 25% to 30% [22]. Vaccination against HPV infection among adolescents before their first sexual experience is one of the most important cervical cancer preventive measures [23]. The provision of HPV vaccines in low- and middle-income countries is a key component of the global action plan to reduce cervical cancer prevalence [24]. The World Health Organization (WHO) recommends giving HPV vaccine to girls between the ages of 9 and 13, before to sexual exposure, because the vaccine is most effective if the girls have not already been infected with HPV [25]. Girls between 9 and 13 years of age should receive a two-dose HPV vaccine regimen with a 6-month interval between doses (0, 6 months), while women aged 16 to 26 years old can receive a three-dose regimen (0, 1, and 6 months or 0, 2, and 6 months), with cervical cancer screening still required after HPV vaccination [26]. Cervical screening can be done with one of three types of tests that are now accessible and commonly utilised namely HPV DNA testing, cytology-based Papanicolaou tests (Pap tests), and unaided visual inspection with acetic acid (VIA). However, there is a lack of public awareness of these tests, particularly in underdeveloped nations [27].

In contrast to low-income countries, the developed countries have seen a decline in the incidence and mortality of HPV infection and cervical cancer due to widespread availability and use of the HPV vaccine and cervical cancer screening [28, 29]. Low awareness and poor knowledge on cervical cancer screening and cervical cancer vaccination approaches has been identified as major barriers to effective cervical cancer prevention in developing countries [30].

Although the HPV vaccine was first introduced in Nigeria in 2009, knowledge of HPV as the causal agent of cervical cancer and HPV vaccination as a preventive intervention against cervical cancer, as well as vaccination uptake by the target demographic of young people, remains low [31]. According to recent research, less than 15% of adolescent girls had got the HPV vaccine [32, 33] and about 10% of women had cervical cancer screenings [34, 35]. Similarly, Awodele et al (2011) reported low cervical screening uptake among more than 150 Nigerian nurses, with 60% reporting never having been checked for cervical cancer [36]. Parents and caregivers of young people in Nigeria have exhibited a lack of understanding about cervical cancer prevention and screening for their children [37, 38]. The lack of such knowledge may have a negative impact on HPV vaccine acceptability and uptake. Furthermore, the low acceptance of cervical screening in Nigeria has been linked to barriers such as lack of awareness, insufficient knowledge of diseases and preventive treatments, insufficient spousal support, misperceptions, stigma, and cultural views resulting in poor outcomes and high mortality rates [29, 39-40].

The American Cancer Society recommends that women should begin cervical cancer screening at age 25 and undergo primary HPV testing every 5 years through age 65 or individuals should be screened every 5 years with co-testing (HPV testing combined with cytology) or cytology alone every 3 years [41]. Since, knowledge and awareness of cervical cancer, screening and vaccination is still low in Nigeria, it was pertinent to carry out this study.

This study was to assess to the level of knowledge, awareness, and attitude regarding cervical cancer, its screening and vaccination among female staff at Afe Babalola University Ado-Ekiti

Study Area

The study was conducted among female workers of Afe Babalola University, Ado Ekiti (ABUAD). ABUAD is a private university in Ado-Ekiti, Ekiti State, Nigeria. It was established in 2009 by Afe Babalola, a lawyer and philanthropist. The programs offered include Science, Law, Engineering, Social and Management Sciences, Pharmacy, Medicine and Health Sciences, and Postgraduate Studies. It has a student population of about 8500 and a staff population of 1255 [42]

Study Design and Duration

This study employed the cross sectional survey design aimed at assessing the level of knowledge, awareness and attitude towards cervical cancer screening and vaccination among female staff of ABUAD, Ekiti State. This study was carried out between April to July 2021.

Study Population

The target population for this study was all the female staff of Afe Babalola University comprising of teaching and non-teaching staff.

Sample Size Determination

The sample size was calculated using Epi-Info for population survey [43].The Confidence interval was set at 95%. The Female staff population size of Afe Babalola is 325 and the expected frequency was set at 62.5% based on a similar study [44]. Confidence limit of 5% was used and contingency at 10% of calculated sample size was also considered.

The calculated sample size was approximately 188 workers

Sampling Technique

The simple random sampling technique was used. The sampling frame for the simple random sample was obtained from the registry. ABUAD has a total of 1255 staff, out of which 325 are female workers. The sample size was achieved by random selection through computer generated codes after assigning numbers to each staff.

Instrument for Data Collection

The 34- item semi-structured adapted questionnaire was used for data collection in this study designed according to the variables being tested in the study. Section A elicited the demographic data of the participants. Section B assessed the level of knowledge and awareness of cervical cancer screening and vaccination among the respondents. Section C determined the attitude of the population towards cervical cancer screening and vaccination. A total of 15 dichotomised “yes and no” questions were used to assess the participants knowledge and awareness while 13 Likert scale questions were used to assess their attitude towards cervical cancer screening and vaccination. A score of 1 was allocated to each correct knowledge question while a zero score was allocated to each wrong answer. A score of 5 represented the highest rank while 1 represented the lowest rank for the Likert scale questions

Validity and Reliability of the Instrument

The research instrument was assessed for face validity by lecturers of the Department of Public Health, College of Medical Health Sciences, Afe Babalola University. Prior to the administration of the questionnaire, a pre-test was done a week before the actual data collection with 10 participants that have similar characteristics to the study population but was not included in the final data. The reliability coefficient was calculated to test for the internal consistencies of response using the Cronbach Alpha coefficient and to determine if the instrument is reliable for the study and a value of 0.72 was obtained.

Data collection

This research questionnaire was self-administered as the questionnaire was simple and clear for the participant questions. The questionnaires were handed out to selected staff in their respective colleges daily and only participants that met the inclusion criteria participated in the study. The questionnaire required an average of 10 minutes to complete.

Data Analysis

Data analysis was conducted using Statistical Package for Social Sciences (SPSS) version 20. The staff socio-demographics, knowledge, awareness and attitude towards cervical cancer screening and vaccination were summarized using frequency counts and percentages. Overall staff knowledge was categorised into Good (>50%) and poor knowledge (<50%). The relationship between demographics, attitude and knowledge of cervical cancer screening and vaccination was carried out using the Pearson’s Chi-square test. All significant differences was set at p<0.05.

Ethical Consideration

Research ethical approval was collected from the Research and Ethics committee of Afe Babalola University, Ado-Ekiti (ABUADREC), and from an informed consent form was given to all selected participants after thorough explanation of the research information to seek their consent and participate in the survey. Confidentiality of each participant was ensured by exclusion of their names and other confidential details when participating in the study.

Demographics of the study participants

A total of two hundred respondents consented to participate in this study and they all filled and returned the study questionnaires representing 100% response rate. The mean age of the participants was 32.81 + 8.164 years with 4.5% (9) within the age range of 50 years and above. More than 70% (140) of the participants were Yoruba while two-thirds (124; 62%) of the participants were teaching staff. Majority of the participants (80.5%) were Christians, while 64% (128) were married. The participant demographics is summarised in Table 1.

Knowledge and awareness of participants on cervical cancer screening and vaccination

About two-thirds (60.5%) of the participants knew the causes of cervical cancer while less than half of the participants (47.5%) admitted that Human Papilloma Virus (HPV) is a sexually transmitted virus that can cause cervical cancer. More than 54% (109) of the workers admitted knowing that cervical cancer is preventable through the use of HPV vaccines while less than one-third of the participants (29.5%) admitted that cervical cancer is only common among older women above the age of 35. Ninety (45%) workers admitted that using a condom when having sexual intercourse can reduce the chance of getting HPV while 31% (62) admitted that HPV vaccine is usually given within a period of six months in three doses (Table 2). Overall, majority (63.5%; 127) of the participants showed good knowledge. One hundred and thirty two workers (66.1%) stated that they were informed by health workers, while 8 (3.8%) were informed by newspaper/magazine. Less than 5% (9) reported that they got their information through television/radio while 8.3% (17), 26.9% (54) and 1.3% (3) got to know about cervical cancer from the internet, friends/peer and church respectively. There was a statistically significant association between religion (p=0.002), but no significant association between marital status (p=0.063) and knowledge of the participants on cervical screening and vaccination (Table 3).

Table 1. Socio-Demographic Characteristics of the Female Workers

Variable		Frequency (n=200)	Percentage (%)
Age	20-29	72	36
	30-39	95	47.5
	40-49	24	12
	50 and above	9	4.5
Ethnicity	Yoruba	143	71.5
	Igbo	38	19
	Hausa	10	5
	Others	9	4.5
Occupation	Teaching Staff	124	62
Occupation	Non-teaching Staff	76	38
College	MHS	70	35
	Sciences	49	23
	SMS	66	33
	Law	14	7
	Engineering	4	2
Religion	Christianity	161	80.5
	Islam	33	16.5
	Other	6	3
Marital Status	Single	66	33
	Married	128	64
	Divorced/Separated	3	1.5
	Widow	3	1.5

Table 2. Knowledge of Workers on Cervical Cancer and Screening and Vaccination

	Statements	Correct (%)	Incorrect (%)
1	I know what causes cervical cancer	121 (60.5)	79 (29.5)
2	HPV is a sexually transmitted virus	95 (47.5)	105 (52.5)
3	Cervical cancer is preventable through the use of HPV vaccines	109 (54.5)	93 (45.5)
4	Using a condom when having sexual intercourse can reduce the chance of getting HPV	90 (45)	110 (55)
5	Cervical cancer is only common among older women above the age of 35	59 (29.5)	141 (70.5)
6	By having only one or few sexual partners one can reduce the chance of getting the HPV	82 (41)	118 (59)
7	Using birth control pills can prevent one from getting HPV thus preventing cervical cancer	26 (13)	174 (87)
8	The screening can only be done on women who are experiencing unusual symptoms	44 (22)	156 (78)
9	HPV is the leading cause of cervical cancer	100 (50)	100 (50)
10	HPV vaccine is usually given within a period of six months in three doses	62 (31)	138 (69)
	Good Knowledge (>50%)	63.5%
	Poor Knowledge (<50%)	36.5%

Key: HPV: Human Papilloma Virus

Table 3. Relationship between Socio-demographic Data, Attitude and Knowledge of Cervical Cancer Screening and Vaccination

Characteristics	Level of knowledge		X²	P-value^a
	Good Knowledge (%)	Poor Knowledge (%)	X²	P-value^a
Age group
20-29	47(37)	25(12.5)	6.419	0.093
30-39	58(29)	37(18.5)
40-49	13(6.5)	11(5.5)
50 and above	9(4.5)	-
Religion
Christianity	108(54)	53(26.5)	12.613	0.002*
Islam	13(6.5)	20(10)
Other	6(3)	-
Marital status
Single	44(22)	22(11)	7.284	0.063
Married	80(40)	48(24)
Divorced/Separated	-	3(1.5)
Widow	3(1.5)	-
Attitude
Positive Attitude	74(37)	18(9)	21.081	<0.001*
Negative Attitude	53(26.5)	55(27.5)	21.081	<0.001*

Key: ^a=Pearson Chi-Square Test; *=statistically significant values

Majority of the participants were aware of cervical cancer (79%, 158) and cervical cancer screening (60%, 120). More than half of the participants (55.5%) were aware of HPV vaccination while 50 (25%) participants reported that they have been vaccinated against HPV.

Attitude towards cervical cancer screening and vaccination

During assessment of the attitude of the participants towards cervical cancer screening and vaccination, it was reported that 48.5% (97) of the workers strongly agreed that they feel uncomfortable with a male doctor performing the colposcopy/pap test and 7.5% (15) strongly agreed that they do not see the need for cervical screening since there are no early clear signs or symptoms. Sixty-eight staff (34%) strongly disagreed that they don’t think the cervical cancer screening and HPV vaccine are necessary while 43.5% (87) of the participants agreed that Pap test is very expensive. Less than 25% (41) strongly agreed that they feel uneasy talking about cancer while 16.5% (33) and 30% (60) workers stated that they don’t think there is any screening site in the primary health care facility close by and that they are scared of a cancer diagnosis and treatment respectively. Overall, less than half of the participants (46%) had a positive attitude towards cervical cancer screening and vaccination. The participant attitude findings towards cervical cancer screening and vaccination is summarised in Table 4. There was a significant relationship between knowledge and attitude of participant (p<0.001) towards cervical cancer screening and vaccination (Table 3).

This study revealed that majority of the participants was aware of cervical cancer, cervical cancer screening and the Human Papilloma Virus. This finding is in contrast with a study in Gondar town, Ethiopia in which 65.1% claimed to have heard of cervical cancer while 21.4% and 18.6% reported to have heard of cervical cancer screening and Human Papilloma Virus respectively [45].

Table 4

Workers’ Attitude Towards Cervical Cancer Screening and Vaccination
S/N	Statement	Responses (%)
S/N	Statement	SA	A	D	SD
1	I feel uncomfortable with a male doctor performing the colposcopy/pap test	97 (48.5%)	51 (25.5%)	39 (19.5%)	13 (6.5%)
2	I do not see the need for cervical screening since there is no sign or symptom	15 (7.5%)	80 (40%)	71 (35.5%)	34 (17%)
3	I do not see the need for HPV vaccination since there is no sign or symptom	14 (7%)	51 (25.5%)	93 (46.5%)	42 (21%)
4	I don’t think the cervical cancer screening and HPV vaccine are necessary	19 (9.5%)	38 (19%)	75 (37.5%)	68 (34%)
5	I think the pap test is very expensive	35 (17.5%)	87 (43.5%)	55 (27.5%)	23 (11.5%)
6	I think the vaccination is very expensive	30 (15%)	80 (40%)	63 (31.5%)	27 (13.5%)
7	I feel uneasy talking about cancer	41 (20.5%)	57 (28.5%)	77 (38.5%)	25 (12.5%)
8	I don’t think there is any screening site in the primary health care faculty close to me	33 (16.5%)	76 (38%)	82 (41%)	9 (4.5%)
9	I am too busy to find time for cervical cancer screening	36 (18%)	60 (30%)	91 (45.5%)	13 (6.5%)
10	It is against my religious belief	10 (5%)	20 (10%)	119 (59.5%)	51 (25.5%
11	It is against my cultural value	20 (10%)	13 (6.5%)	104 (52%)	63 (31.5%)
12	I don’t think my partner would allow me to participate in the screening	11 (5.5%)	19 (9.5%)	107 (53.5%)	63 (31.5%)
13	I am scared of a cancer diagnosis and treatment	41 (20.5%)	60 (30%)	61 (30.5%)	38 (19%)
	Positive Attitude	92 (46%)
	Negative Attitude	108 (54%)

Key: Sa: Strongly Agree = 5 A: Agree = 4 D: Disagree = 2 Sd: Strongly Disagree = 1

This difference in awareness could be due to difference in study population in which majority of the respondents were teaching staff while an undergraduate population was used in the study done in Ethiopia. Half of the participants were aware of HPV vaccination while one-fourth of the participants had been vaccinated. This is in contrast to findings from a study conducted in Lagos which showed that less than 2% of the participants had heard of HPV vaccination and none had been vaccinated [46]. This difference might be due to the lack of health education programs regarding cervical cancer vaccination in the urban slum which is believed to be the problem of most developing countries [47]. The level of awareness and knowledge of cervical cancer, its etiology, screening as well as HPV vaccination in women can greatly influence their participation in screening and vaccination programs [48].

Health workers were reported as the major source of information about cervical cancer by the study participants followed by friends, television/radio, and the internet. This is quite dissimilar to a study done in China where 35.2% reported to have heard of cervical cancer from friends, 33.9% responded that they heard of cervical cancer through television, and 15.5% by other means [49].

The difference might be due to differences in media coverage between the countries, health service access and utilization levels. The source of information can also explain the good awareness shown by the study participants. Healthcare professionals with adequate knowledge can play a huge role in influencing the beliefs and practices of the general public in a positive way by raising awareness of the general public [50].

Less than half of the participants admitted that Human Papilloma Virus (HPV) is a sexually transmitted virus. This is contrary to the study done in Lagos where 76.2% agreed that Human Papilloma Virus (HPV) is a sexually transmitted virus [51]. This difference might again emerge from lack of insufficient health education programs regarding cervical cancer.

The success of cervical cancer prevention and control is largely dependent on cervical cancer screening programmes and human papillomavirus vaccinations, according to the WHO [52]. In this study, more than 50% of the participants admitted knowing that cervical cancer is preventable. This finding is consistent with the study done by Mengesha et al. (2020) in which 78% of the participant agreed that cervical cancer is preventable [45]. More efforts should be put into developing more cervical cancer screening and vaccination programmes and centres to achieve adequate cervical cancer prevention and control.

Majority of the study participants showed good knowledge of cervical cancer screening and vaccinations. This is in contrast with findings in other developing countries where the women had poor level of knowledge of cervical cancer and its prevention [53, 54]. There was also a statistically significant association between participant knowledge and attitude towards cervical cancer screening and vaccination which is similar to studies carried out in low income countries where a direct relationship between women's knowledge and attitudes about cervical cancer and its prevention has been documented [55, 56].

Regarding the assessment of study participants’ attitude, more than 50% of the participants reported that they feel uncomfortable with a male doctor performing the colposcopy/pap test. This is similar to the study done by Tavafian (2012) where 45.2% of the respondents agreed that lack of female screeners in health facilities contribute to not screening [57]. This is may be as a result of religious reasons. Also, majority disagreed that they do not see the need for cervical screening since there is no sign or symptom and that they don’t think the cervical cancer screening and HPV vaccine are necessary. Majority of the workers also agreed that they are scared of a cancer diagnosis and treatment. This is in agreement with a study done by Malhotra and colleagues where 32.78% agreed that there is need for cervical screening since there is no sign or symptom, and 8.61% agreed that cervical cancer screening and HPV vaccine are not necessary [58]. Similarly, results of a study by Ifediora and Azuike (2018) reported that 24% of the respondents agreed they worry about the findings of the screening, 15.2% of the respondents agreed they would be too busy to take cervical screening, and 12.1% of the respondents agreed that screening is not necessary [59]. Majority of the participants of this study showed negative attitude towards cervical cancer screening and vaccination which is similar, though lower, than what was obtained from a study carried out in Qatar which revealed that over 60% had a poor attitude towards prevention and screening test of cervical cancer [53]. This finding indicates that despite the higher level of women’s knowledge regarding cervical cancer and its prevention, majority still showed somewhat poor attitude. This could be due to influence of other factors that could impact health-seeking behaviours apart from health-related knowledge [60]. Further studies should be done to identify other factors that can influence the attitude of females towards cervical cancer screening and vaccinations and interventions should also be put in place to combat these factors.

Limitations

This research assessed the awareness, knowledge and attitude towards cervical cancer among the female workers within the institution of Afe Babalola University only and this should be considered in the generalizability of the study findings.

The study participants showed good knowledge and awareness but poor attitude towards cervical cancer screening and vaccinations. There is a need to improve the population’s attitude and eliminate misconceptions. Comprehensive health education on the utilization of cervical cancer screening and vaccination which can be achieved through community health services programs and campaigns should be encouraged. Further studies should be done to identify other factors that can influence the attitude of females towards cervical cancer screening and vaccinations and interventions put in place to combat these factors.

HPV

Human Papilloma Virus

IgG

Immunoglobulin G

VIA

Visual Inspection with Acetic Acid

WHO

World Health Organisation

HIV

Human Immunodeficiency Virus

Pap Test

Papanicolaou Tests

ABUAD

Afe Babalola University, Ado-Ekiti

ABUADREC

Afe Babalola University Research Ethics Committee

SPSS

Statistical Package for Social Sciences

Ethics approval and consent to participate

This study obtained ethical approval from Afe Babalola University Research Ethics Committee (ABUADUREC). All selected participants used for this study were informed that their participation is voluntary and informed consent was sought from all participants prior to their participation. All methods were carried out in accordance with relevant guidelines and regulations.

Consent of publication

Not Applicable

Availability of data and materials

Data material used in this study was confidential and will be made available by the corresponding authors on request.

Competing interests

The authors have no competing interests to declare that are relevant to the content of this article.

Funding

The authors did not receive support from any organization for the submitted work.

Authors’ contributions

All authors contributed to the study conception and design. Material preparation and data collection were performed EO, TO, and LO. Data analysis was performed by ENO and OK. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors wish to thank all participants that gave consent to participate in this study

World Health Organization. Cervical cancer. 2020. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer Accessed 2 April 2022.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Small W, Bacon MA, Bajaj A. Cervical cancer: A global health crisis. Cancer. 2017;123(13):2404–12. https://doi.org/10.1002/cncr.30667.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86. https://doi.org/10.1002/ijc.29210.
Idehen EE, Koponen P, Härkänen T, Kangasniemi M, Pietilä AM, Korhonen T. Disparities in cervical screening participation: A comparison of Russian, Somali and Kurdish immigrants with the general Finnish population. Int J Equity Health. 2018;17:56. https://doi.org/10.1186/s12939-018-0768-2.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer, 2020. https://gco.iarc.fr/today/data/factsheets/populations/566-nigeria-fact-sheets.pdf. Accessed 2 April 2022.
Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 22 October 2021. https://hpvcentre.net/statistics/reports/XWX.pdf. Accessed 2 April 2022.
Aminu M, Gwafan JZ, Inabo HI, Oguntayo A, Ella E, Koledade A. Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria. Int J Womens Health. 2014;6:479.
Adegbesan OM, Okunade K, Omilabu S. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014;2:625–30.
Okunade KS, Nwogu CM, Oluwole AA, Anorlu R, et al. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the outpatient clinics of a university teaching hospital in Lagos, Nigeria. Pan Afr Med J. 2017;28:227.
Golfetto L, Alves EV, Martins TR, Sincero TC, Castro JB, Dannebrock C, et al. PCR-RFLP assay as an option for primary HPV test. Braz J Med Biol Res. 2018;51:e7098. https://doi.org/10.1590/1414-431x20177098.
Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99. https://doi.org/10.1086/657321.
Kocjan BJ, Bzhalava D, Forslund O, Dillner J, Poljak M. Molecular methods for identification and characterization of novel papillomaviruses. Clin Microbiol Infect. 2015;21:808–16. https://doi.org/10.1016/j.cmi.2015.05.011.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. https://doi.org/10.3322/caac.21262.
Kolawole O, Ogah J, Alabi O, Suleiman M, Amuda O, Kolawole F, et al. Utilization of human papillomavirus DNA detection for cervical cancer screening in women presenting with abnormal cytology in Lokoja, Nigeria. Jundishapur J Microbiol. 2015;8:e22620.
Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: Past, present and future. Gynecol Oncol Rep. 2017;21:101–08. https://doi.org/10.1016/j.gore.2017.07.009.
Min KJ, Lee JK, So KA, Kim MK. Association Between Passive Smoking and the Risk of Cervical Intraepithelial Neoplasia 1 in Korean Women. J Epidemiol. 2018;28:48–53. https://doi.org/10.2188/jea.JE20160118.
Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2016;389(10071):847–60. https://doi.org/10.1016/S0140-6736(16)31392-7.
IARC/WHO. GLOBOCAN: Estimated cancer incidence, mortality and prevalence worldwide in 2018. Cervical Cancer Fact Sheet. 2018. https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-Uteri-fact-sheet.pdf. Accessed 5 April 2022.
Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. https://www.who.int/publications/i/item/9789240014107. Accessed 3 April 2022.
Abraham A, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62(4):405–13.
World Health Organization. Country cancer profile. China. 2014. http://www.who.int/cancer/country-profiles/chn_en.Pdf. Accessed 2 April 2022.
Human Papillomavirus Vaccination. The American College of Obstetricians and Gynaecologists Committee Opinion no. 588 Obs& Gyn. 2014;123:712–18.
Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: A systematic review. PLoS ONE. 2014;9(3):e90912.
WHO, World Health Organization Human papillomavirus vaccines WHO position. paper Wkly Epidemiol Rec. 2009;15(84):117–32.
Akinola OI, Aimakhu CO, Ezechi OC, Fasubaa OB. Society of Obstetrics and Gynecology of Nigeria – Clinical practice guidelines: Guidelines for the prevention of cervical cancer. Trop J Obstet Gynaecol. 2018;35:371–76.
Jassim G, Obeid A, Al Nasheet HA. Knowledge, attitudes, and practices regarding cervical cancer and screening among women visiting primary health care Centres in Bahrain. BMC Pub Health. 2018;18(1):128.
Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vacc. 2008;26:29–41.
Drolet M, Benard E, Perez N, Brisson M, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394:497–509.
Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Women’s Health. 2015;15:1–7.
Isara AR, Osayi N. 2021. Knowledge of Human Papillomavirus and Uptake of its Vaccine among Female Undergraduate Students of Ambrose Alli University, Ekpoma, Nigeria. J Prim Care Community Health. 2021;33(1):64–75. https://doi.org/10.4314/jcmphc.v33i1.6.
Ndikom CM, Oboh PI. Perception, acceptance and uptake of Human papillomavirus vaccine among female adolescents in selected secondary schools in Ibadan. Nigeria Afr J Biomed Res. 2017;20:237–44.
Ogochukwu TN, Akabueze J, Ezeome IV, Aniebue U, Oranu E. Vaccination against human papilloma virus in adolescent girls: mother’s knowledge, attitude, desire and practice in Nigeria. J Infect Dis Prev Med. 2017;5:2.
Wright KO, Aiyedehin O, Akinyinka MR, Ilozumba O. Cervical cancer: community perception and preventive practices in an urban neighborhood of Lagos (Nigeria). ISRN Prev Med. 2014;14:1–9.
Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of cervical cancer screening uptake among women in Ilorin, North Central Nigeria: a community-based study. J Canc Epidemiol. 2016;16:1–8.
Awodele O, Adeyomoye AA, Awodele DF, Kwashi V, Awodele IO, Dolapo DC. A study on cervical cancer screening amongst nurses in Lagos University Teaching Hospital, Lagos, Nigeria. J Cancer Educ. 2011;26(3):497–504.
Ifedioha CO, Azuike AC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Trop Med Int Health. 2018;23(7):714–23.
Azuogu BN, Umeokonkwo CD, Azuogu VC, Onwe OE, Okedo-Alex IN, Egbuji CC. Appraisal of willingness to vaccinate daughters with human papillomavirus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria. Niger J Clin Pract. 2019;22:1286–91.
Modibbo FI, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016;6:e008533.
Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care. 2017;26:e12444.
Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society Ca-Cancer. J Clin. 2020;70(5):321–46. https://doi.org/10.3322/CAAC.21628.
Afe Babalola University. A Private University of Higher Learning. https://www.abuad.edu.ng/. Accessed 2 April 2022.
Population Survey or Descriptive Study. | StatCalc | User Guide | Support | Epi InfoTM | CDC. https://www.cdc.gov/epiinfo/user-guide/statcalc/samplesize.html. Accessed April 7 2022.
Alwahaibi N, Alsalami W, Alramadhani N, Alzaabi A. Factors Influencing Knowledge and Practice Regarding Cervical Cancer and Pap smear Testing among Omani Women. Asian Pac J Cancer Prev. 2018;19(12):3367–74. https://doi.org/10.31557/apjcp.2018.19.12.3367.
Mengesha A, Messele A, Beletew B. Knowledge and attitude towards cervical cancer among reproductive age group women in Gondar town, North West Ethiopia. BMC Public Health. 2020;20:209. https://doi.org/10.1186/s12889-020-8229-4.
Olubodun T, Odukoya OO, Balogun MR. Knowledge, attitude and practice of cervical cancer prevention, among women residing in an urban slum in Lagos, South West, Nigeria. Pan Afr Med J. 2019;32:130. https://doi.org/10.11604/pamj.2019.32.130.14432.
Ali F, Kuelker R, Wassie B. Understanding cervical cancer in the context of developing countries. Ann Trop Med Public Health. 2012;5(1):3.
Drokow EK, Zi L, Han Q, Effah CY, Agboyibor C, Sasu E, et al. Awareness of Cervical Cancer and Attitude Toward Human Papillomavirus and Its Vaccine Among Ghanaians. Front Oncol. 2020;10:1651. https://doi.org/10.3389/fonc.2020.01651/bibtex.
Abudukadeer A, Azam S, Mutailipu A, Qun L, Guilin G, Mijiti S. Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer. World J Surg Onc. 2015;13:110. https://doi.org/10.1186/s12957-015-0531-8.
Heena H, Durrani S, Alfayyad I, Riaz M, Tabasim R, Parvez G, et al. Knowledge, Attitudes, and Practices towards Cervical Cancer and Screening amongst Female Healthcare Professionals: A Cross-Sectional Study. J Oncol. 2019;19:1–9. https://doi.org/10.1155/2019/5423130.
Shu NE, Abiola AO, Akodu BA, Bassey BA, Misago N. Knowledge, attitudes and preventive practices for human Papilloma virus infection among female sex workers in Lagos metropolis. Pan Afr Med J. 2020;36:278. https://doi.org/10.11604/pamj.2020.36.278.17912.
World Health Organization (WHO), Comprehensive Cervical Cancer Control: A guide to essential practice, 2nd editor. 2014. http://apps.who.int/iris/bitstream/handle/10665/144785/9789241548953_eng.pdf. Accessed 4 April 2022.
Al Meer FM, Aseel MT, Al Khalaf J, Al Kuwari MG, Ismail MF. Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar. East Mediterr Health J 2011: 17 (11): 855–61. https://doi.org/10.26719/2011.17.11.856.
Shrestha J, Saha R, Tripathi N. Knowledge, attitude and practice regarding cervical cancer screening amongst women visiting tertiary Centre in Kathmandu. Nepal Nepal J Med Sci. 2013;2(2):85–90.
Al-Naggar R. Practice and barriers towards pap smear test from a public hospital in Malaysia. J Community Med Health Edu. 2012;2(132):2.
Mirzaei-Alavijeh M, Karami-Matin B, Jalilian F, Rakhshani F, Mahboubi M, Emdadi S. Pap smear test promotion among women: an educational intervention based on theory of planned behavior. J Biol Today's World. 2014;3(4):100–3.
Tavafian SS. Predictors of cervical cancer screening: an application of health belief model. In: Rajkumar, R. eds. Topics on cervical cancer with an advocacy for prevention. London: IntechOpen. 2012. https://www.intechopen.com/chapters/30744. Accessed 8 April 2022.
Malhotra N, Taneja N, Shankar R, Pal A, Chawla B, Awasthi A, et al. Knowledge, attitude & practice towards cervical cancer screening among women globally – A systematic review. J Women's Health Dev. 2020;3(20):194–210.
Ifediora CO, Azuike EC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Trop Med Int Health. 2018;23(7):714–23. https://doi.org/10.1111/tmi.13070.
Luo Y, Yao L, Zhou L, Yuan F, Zhong X. Factors influencing health behaviours during the coronavirus disease 2019 outbreak in China: an extended information-motivation-behaviour skills model. Public Health. 2020;185:298–305. https://doi.org/10.1016/J.PUHE.2020.06.057.

No competing interests reported.

Download PDF

Journal Publication

published 03 May, 2023

Read the published version in BMC Women's Health →

Editorial decision: Major revision
30 Mar, 2023
Reviews received at journal
29 Mar, 2023
Reviews received at journal
27 Mar, 2023
Reviewers agreed at journal
17 Mar, 2023
Reviewers agreed at journal
17 Mar, 2023
Reviewers agreed at journal
17 Mar, 2023
Reviewers agreed at journal
17 Mar, 2023
Reviewers invited by journal
17 Mar, 2023
Editor assigned by journal
17 Mar, 2023
Editor invited by journal
23 Dec, 2022
Submission checks completed at journal
23 Dec, 2022
First submitted to journal
18 Dec, 2022

You are reading this latest preprint version

Cervical Cancer Screening and Vaccination: Knowledge, Awareness, and Attitude of Female Staff in a Nigerian University

Status:

Journal Publication

Version 1

Abstract

Background

Methods

Results

Discussion

Key: Sa: Strongly Agree = 5 A: Agree = 4 D: Disagree = 2 Sd: Strongly Disagree = 1

Limitations

Conclusion

Abbreviations

Declarations

References

Additional Declarations

Status:

Journal Publication

Version 1